We show that this mechanism is exploitable in cancer as blockade of retinoic acid production by inhibiting cancer cell-expressed ALDH1A3 allows Th17 T cell expansion while suppressing Th2 T cells. This evidence concerns the gene ALDH1A3 and cancer.